Volume 20, Number 2—February 2014
Research
Human Antibody Responses to Avian Influenza A(H7N9) Virus, 2013
Table 2
Patient no. | H7N9 Ct for FluA, H7, N9 tests | Concomitant infection | ALT | AST | Creat | BUN | WBC | Temp | Serum collection, d† |
---|---|---|---|---|---|---|---|---|---|
1 | 28.47, 32.87, 32.55 | No | 39 | 77 | 74.3 | NA | 3.5 | 39.5 | 20 |
2 | 23.46, 24.34, 22.91 | No | 15 | 41 | 75.4 | 4.3 | 3.2 | 39.3 | 24 |
3 | 21.44, 34.76, 29.70 | No | 62 | 45 | 84.2 | 5.78 | 5.95 | 39.7 | 26 |
4 | 24.41, 25.91, 28.59 | No | NA | NA | NA | NA | 10.99 | 39.7 | 35 |
5 | 34.64, 31, Negative | No | 36 | 40 | 65.0 | 6.8 | 4.7 | 39.0 | 35 |
6 | 31.99, 26.1, Negative | No | NA | NA | NA | NA | 4.9 | 40.1 | 25, 31 |
7 | 29.89, 30.91, 27.63 | Candida albicans | 66 | 79 | 84.0 | 7.5 | 6.62 | 38.2 | 17, 27 |
8 | 30.26, 30.96, 30.6 | No | 31 | 35 | 84.0 | 41.0 | 4.1 | 38.9 | 25 |
9 | 37.49, 36.6, 36.95 | No | 33 | 78 | 102.0 | 43.0 | 5.64 | 39.5 | 24, 30 |
10 | 29.7, 26.43, 21.68 | No | 129 | 89 | 85.0 | 4.76 | 8.62 | 38.6 | 29 |
11 | 34.88, 36.18, 18.43 | No | 14 | 39 | 196.0 | 6.3 | 8.31 | 38.6 | 33 |
12 | 33.91, 33.66, Negative | No | 86 | 144 | 83.0 | 3.6 | 7.11 | 39.0 | 37 |
13 | 30.48, 37.94, Negative | No | 37 | 55 | 46.0 | 6.8 | 8.0 | 38.5 | 18 |
14 | 16.3, 16.1, 16.4 | No | NA | NA | NA | NA | 3.79 | 40.0 | 31 |
15 | 30.8, 33.0, 32.7 | No | NA | NA | NA | NA | 6.96 | 38.6 | 33 |
16 | 37.26, 38.48, 27.65 | No | NA | NA | NA | NA | 7.68 | 39.0 | NA |
17 | 30.73, 32.1, 28.85 | No | 100 | 30 | NA | NA | 11.2 | 39.5 | NA |
18 | 36.05, 35.75, 37.52 | No | 132 | 239 | 123.2 | 12.8 | 8.9 | 39.4 | NA |
19 | 27.21, 30.4, 30.62 | Acinetobacter baumannii | 25 | 19 | 88.7 | 2.85 | 7.93 | 39.8 | NA |
20 | 28.72, 27.76, 30.08 | Fungus | NA | NA | NA | NA | 9.5 | 38.5 | NA |
21 | 27.84, 35.23, 29.6 | No | 36 | 207 | 162.7 | 17.94 | 4.06 | 36.5 | NA |
*Ct , cycle threshold; ALT, alanine transaminase, U/L; AST, aspartate transaminase, U/L; Creat, creatinine, μmol/L; BUN, blood urea nitrogen, μmol/L; WBC, white blood cell (leuckocyte) count, ×109/L; temp, body temperature, °C; NA, not available.
†Convalescent-phase; days after symptom onset.
1These authors contributed equally to this article and are co–first authors.
2These authors contributed equally to this article and are co–senior authors.
Page created: January 17, 2014
Page updated: January 17, 2014
Page reviewed: January 17, 2014
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.